Transthyretin familial amyloid polyneuropathy is suspected when patients develop progressive peripheral sensory-motor neuropathy, associated with family history of neuropathy (94%) and/or autonomic dysfunction, or gastrointestinal disorder (40−48% in early onset). The gene discussed is TTR; the disease is digestive system disorder.